πŸ‡ΊπŸ‡Έ FDA
Patent

US 11819516

Immunotherapy

granted A61KA61K2239/38A61K2239/49

Quick answer

US patent 11819516 (Immunotherapy) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Nov 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Nov 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K2239/38, A61K2239/49, A61K38/1774, A61K40/11